z-logo
open-access-imgOpen Access
A Comparative Study between the Efficacy of Intratympanic Steroid Injection and Conventional Medical Treatment in Resistant Cases of Otitis Media with Effusion
Author(s) -
Rabi Hembrom,
Mukesh Kumar Singh,
Sabyasachi Ghosh,
Sabyasachi Gon,
Indranil Das,
Tapas Kumar Mahata,
Subanta Bhaumik
Publication year - 2021
Publication title -
bengal journal of otolaryngology and head neck surgery
Language(s) - English
Resource type - Journals
eISSN - 2395-2407
pISSN - 2395-2393
DOI - 10.47210/bjohns.2021.v29i1.450
Subject(s) - medicine , audiogram , otitis , hearing loss , dexamethasone , effusion , medical treatment , surgery , tympanum (architecture) , audiology , audiometry , tympan , anesthesia , intensive care medicine , myringotomy
Otitis media with effusion (OME) is a multifactorial disease and the treatment options for it are limited and controversial. The aim of the present study was to compare the efficacy of intratympanic steroid injection and conventional medical treatment  in resistant cases of OME with hearing loss.Materials and MethodsA comparative study was conducted among 20 patients of OME with hearing loss, resistant to conventional medical treatment between December 2019 to November 2020. ‘Intratympanic dexamethasone injection’ (ITDI) was given every week for 3 consecutive weeks to one group and the other group continued to receive medical treatment. Hearing was assessed by performing pure tone audiogram before every ITDI and also at 12 weeks follow up after completion of treatment.ResultsHearing improvement was found to be better in the group which received ITDI (Mean AC-PTA hearing gain = 22.88 dB) than the group where conventional medical treatment was continued (Mean AC-PTA hearing gain = 6.83 dB).ConclusionIntratympanic dexamethasone injection has significantly better outcome in term of improvement of hearing loss in resistant cases of OME than conventional medical management, and is an effective and safe therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here